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The class I PI3K family of lipid kinases plays an important
role in integrin IIb3 function, thereby supporting thrombus
growth and consolidation. Here, we identify Ras/Rap1GAP
Rasa3 (GAP1IP4BP) as a major phosphatidylinositol 3,4,5-tris-
phosphate-binding protein in human platelets and a key regula-
tor of integrinIIb3 outside-in signaling.We demonstrate that
cytosolic Rasa3 translocates to the plasmamembrane in a PI3K-
dependent manner upon activation of human platelets. Expres-
sion of wild-type Rasa3 in integrin IIb3-expressing CHO cells
blocked Rap1 activity and integrin IIb3-mediated spreading
on fibrinogen. In contrast, Rap1GAP-deficient (P489V) and
Ras/Rap1GAP-deficient (R371Q) Rasa3 had no effect. We fur-
thermore show that two Rasa3 mutants (H794L and G125V),
which are expressed in differentmousemodels of thrombocyto-
penia, lack both Ras and Rap1GAP activity and do not affect
integrinIIb3-mediated spreading of CHO cells on fibrinogen.
Platelets from thrombocytopenic mice expressing GAP-defi-
cient Rasa3 (H794L) show increased spreading on fibrinogen,
which in contrast to wild-type platelets is insensitive to PI3K
inhibitors. Together, these results support an important role for
Rasa3 in PI3K-dependent integrin IIb3-mediated outside-in
signaling and cell spreading.
Integrins are a family of heterodimeric cell adhesion recep-
tors that play critical roles in mediating cell adhesion to adja-
cent cells and to extracellular matrix, thereby contributing to
embryonic development, tissue formation, maintenance and
repair, immune responses, and hemostasis. These functions are
carried out by bidirectional signaling, which allows integrins to
finelymediate cellular responses. Integrins usually exist in a low
affinity state but upon cellular stimulation will enter a high
affinity ligand-binding state through a process called inside-out
signaling. In turn, integrin ligation and clustering triggers out-
side-in signaling, which is critical in regulating cell spreading
and retraction important for cell migration, proliferation, and
differentiation.
Platelets provide a highly tractable model for the study of
integrins in human tissue, because cell spreading and retraction
in platelets is critical for their hemostatic and thrombotic func-
tion. Dysregulation of the major platelet integrin IIb3 con-
tributes to the risk/progression of thrombosis in myocardial
infarction and ischemic stroke and bleeding in Glanzmann
thrombasthenia. In platelets, both inside-out and outside-in
signaling from integrin IIb3 leads to the activation of class I
PI3K isoforms (1–3), resulting in the generation of the lipid
second messenger phosphatidylinositol 3,4,5-trisphosphate
(PI(3,4,5)P3).2 Pharmacological and genetic approaches have
revealed that PI3K supports platelet function downstream of
multiple receptors to promote platelet aggregation and throm-
bus stability (4–7). Although details of the PI3K-dependent
molecular mechanisms of inside-out signaling in platelets are
becoming clearer (8), details of PI3K dependent outside-in sig-
naling, important for cytoskeletal rearrangements to promote
cell spreading (4, 9, 10), are more poorly understood. One
potential mechanism is for PI3K to enhance activation of the
small GTPase Rap1b (4, 11–13), because this has been shown to
be critical for normal hemostasis and thrombosis through reg-
ulation of both integrin IIb3 inside-out and outside-in signal-
ing (14–17).
Here we addressed the hypothesis that dual Rap and Ras
GTPase-activating protein (GAP) Rasa3 (or GAP1IP4BP) (8,
18–20) plays a crucial role in PI3K-mediated outside-in signal-
ing from integrin IIb3. We established that: (i) Rasa3 is a
major binding partner for PI(3,4,5)P3 in human platelets and
that its membrane association is up-regulated in a PI3K/PI
(3,4,5)P3-dependent manner upon platelet activation; (ii) the
activity state of Rap1, but not Ras, is regulated by PI3K/Rasa3 in
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human platelets; (iii) Rasa3 colocalizes with integrin IIb3 in
human platelets; (iv) Rasa3 mutants (H794L and G125V),
which are expressed in thrombocytopenic mice, lack both Ras
and Rap1GAP activity; and (v) that integrin IIb3 outside-in
signaling is controlled by Rasa3 Rap1GAP activity and PI3K-
mediated inhibition of Rasa3.We therefore propose that integ-
rin IIb3-stimulated PI3K activity contributes to Rap1 activa-
tion and cell spreading through inhibition of Rasa3 Rap1GAP
activity.
Results
Rasa3 Is a Highly Abundant Platelet PI(3,4,5)P3-binding
Protein—One of the mechanisms by which PI3K contributes
to platelet function is through the recruitment of PI(3,4,5)
P3-binding proteins to the plasma membrane. To identify
PI(3,4,5)P3-binding proteins in human platelets, we used an
unbiased affinity proteomics approach utilizing PI(3,4,5)P3-
coated beads, coupled to LC-MS/MS analysis. This identified
the dual Ras/Rap1GAPprotein Rasa3 (Fig. 1A) as a highly abun-
dant PI(3,4,5)P3-binding protein from human platelet lysates
(Fig. 1B). Indeed, Rasa3 and the well characterized PI(3,4,5)P3-
specific binding protein Btk were the most abundant proteins
identified in our screen.
Western blot analysis confirmed that platelet Rasa3 was cap-
tured on PI(3,4,5)P3-coated beads with a high abundance and
specificity (Fig. 1C). Indeed, Rasa3 did not bind to control
beads, and preincubation of platelet lysates with competing
free PI(3,4,5)P3 abolished the capture of Rasa3 on PI(3,4,5)P3-
coated beads. These approaches established that the binding
of Rasa3 to the beads was fully dependent on PI(3,4,5)P3 (Fig.
1C). Rasa3 is known to be expressed in platelets (21, 22), and
we detected Rasa3 and its previously characterized sub-
strates Ras (using a pan-Ras antibody that detects H-Ras,
K-Ras, and N-Ras) and Rap1 in both human and mouse
platelets (Fig. 1D).
The Activity State of Rap1, but Not Ras, Is Regulated by PI3K
and P2Y12 in Platelets—Rap and Ras GTPases are the endoge-
nous targets for Rasa3 (18).Members of both families are highly
expressed in platelets and are activated upon stimulation with
various agonists (21–23). These data suggest that Rasa3 may
regulate platelet function by controlling Rap1/Ras activity
levels. The later sustained phase of thrombin-mediated Rap1
activation was strongly reduced in the presence of the pan-
PI3K inhibitor wortmannin (Fig. 2A). The P2Y12 antagonist
AR-C66096 also inhibited the later phase of Rap1 activation
(Fig. 2B), suggesting that sustained Rap1 activation is depen-
dent on autocrine ADP release and subsequent activation of
the P2Y12/PI3K pathway. The early phase of Rap1 activation
was unaffected by wortmannin or AR-C66096, which is in
FIGURE 1.Rasa3binds to PI(3,4,5)P3 and is highly expressed in platelets.A, Rasa3 domain structure. Rasa3 consists of twoN-terminal C2 domains (C2A and
C2B), a central RasGAP-related domain (RasGAP), and a C-terminal pleckstrin homology (PH)/Btk moiety. B, summary of proteomics data. Rasa3 and Btk were
captured on PI(3,4,5)P3-coated (PIP3) beads after incubation with human platelet lysate. The total score of the protein is the sum of all peptide Xcorr values for
that protein above the specified score threshold. The area is the mean of the area of the three most intense unique peptides matched to that protein. The
coverage values indicate the percentages of the protein sequence covered by the identified peptides. PSM indicates the total number of identified peptide
sequences for the protein, and the far-right column shows the number of unique peptide sequences identified for the protein. Rasa3 and Btkwere identified in
three independentexperiments fromwhich themeanvalueswere calculated.C,WesternblottingconfirmationofRasa3andBtk capturedonPI(3,4,5)P3-coated
beads. Human platelet lysate was incubated with uncoated control beads, PI(3,4,5)P3-coated beads (PIP3 beads), or PI(3,4,5)P3-coated beads following prein-
cubation of the lysate with competing free PI(3,4,5)P3 (PIP3 beads PIP3). The input material for each sample was blotted for Rasa3, Btk, and -tubulin as a
loading control. The blots are representative of four independent experiments. D, lysates from human platelets (hPlt), mouse platelets (mPlt), and CHO cells
were subjected to immunoblotting to analyze the expression of Rasa3 and its substrates Rap1 andRas. Inputmaterial for each cell typewasmatchedbymeans
of protein assay. The blots are representative of three independent experiments.
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agreement with the role of PLC/CalDAG-GEFI and not
P2Y12/PI3K in the initial activation of Rap1 (24). In contrast,
Ras activation was unaffected by inhibition of PI3K, although
there was a trend for maximal Ras activation to be sup-
pressed (Fig. 2C). These results demonstrate that sustained
Rap1, but not Ras, activation in human platelets is a PI3K-
dependent process.
Rasa3 Is Predominantly Localized to the Membrane in Close
Association with Integrin IIb3—Previous studies reported
that Rasa3 is constitutively membrane-bound by binding phos-
phatidylinositol 4,5-bisphosphate (PI(4,5)P2) (25) but is still
sensitive to PI(3,4,5)P3 generation in the plasma membrane
(26). To determine the effect of thrombin stimulation and
PI3K/P2Y12 inhibition on the localization of Rasa3 in platelets,
we performed fractionation studies.Over 75%of Rasa3 in plate-
lets was found in the membrane fraction of resting platelets
(Fig. 3, A and B). Following thrombin treatment, there was a
significant increase inmembrane-localized Rasa3, which corre-
lated with a decrease of Rasa3 in the cytosolic fraction (Fig. 3,A
and B). Blocking PI3K activation, with either the generic PI3
kinase inhibitor wortmannin or the PI3K p110 inhibitor
TGX-221, or blocking P2Y12 with AR-C66096 prevented the
thrombin-mediated increase in the membrane localization of
Rasa3, with no effect on basal localization (Fig. 3, A and B, and
data not shown). Three-dimensional immunofluorescence
studies revealed that Rasa3 and integrin IIb3 show a high
FIGURE 2. Sustained Rap1 activation is dependent on PI3K and P2Y12, whereas Ras activation is PI3K-independent. Human washed platelets were
incubated with 100 nMwortmannin (Wtm), 1M AR-C66096 (ARC), or vehicle control (0.2%DMSO) for 10min prior to stimulation with 0.2 unit/ml -thrombin
for the indicated time. Rap1-GTP (A and B) or Ras-GTP (C) was extracted from platelets lysates by GST-RalGDS-RBD or GST-Raf1RBD pulldown, respectively.
Pulldown samples were immunoblotted for Rap1 or Ras, and total lysate controls were immunoblotted for Rap1, Ras, or pAktS473 and total Akt. The results are
expressed as the percentage of the maximum Rap1-GTP (A, n 4; B, n 5) or Ras-GTP (C, n 6) detected using densitometry. The data are expressed as the
means standard deviation, and statistical analysis is presented as paired Student’s t test for each time point to show the effect of wortmannin or AR-C66096
compared with DMSO control (**, p 0.01; ***, p 0.001).
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degree of colocalization on intracellular vesicles and the plasma
membrane, more so than between integrin IIb3 and Rap1
(Fig. 3,C andD). Rap1 showed a cytosolic distribution with low
levels of colocalizationwith Rasa3 andmoved to themembrane
region upon thrombin stimulation (Fig. 3, C and D). Together,
these results demonstrate that Rasa3 localization in human
platelets is regulated by agonist-stimulated PI3K activity and is
closely associated with integrin IIb3.
FIGURE 3. Rasa3 translocates to the plasma membrane upon agonist stimulation in a PI3K/P2Y12-dependent manner and colocalizes with integrin
IIb3. A, humanwashed platelets were incubated with 100 nMwortmannin (Wtm), 1M AR-C66096 (ARC), or vehicle control (0.2% DMSO) for 10min prior to
stimulation with 0.2 unit/ml -thrombin (T) for 5 min. Cytosolic and membrane fractions were separated by ultracentrifugation and immunoblotted along-
side a platelet whole cell lysate (WCL) for Rasa3, Rap1, ERK (cytosolic control), FcR (membrane control), and talin. The blots are representative of three
independent experiments. B, quantification of Rasa3 levels in cytosol and membrane fractions from platelet fractionation experiments (n 3). The data are
expressed as means standard deviation, and statistical analysis shows the effect of thrombin vehicle control, thrombin wortmannin, or thrombin
AR-C66096 compared with basal control (*, p 0.05). C and D, platelets stimulated with 0.2 unit/ml -thrombin for 5 min or untreated platelets were fixed in
4% paraformaldehyde and spun onto glass coverslips. Adhered platelets were permeabilized and stained with antibodies against integrin IIb3, Rasa3, and
Rap1. Localization was identified using Alexa Fluor 568 (integrin IIb3, magenta), Alexa Fluor 488 (Rasa3, green), and Alexa Fluor 350 (Rap1, blue) secondary
antibodies. Images were captured using a spinning disk confocal module (PerkinElmer UltraVIEW ERS 6FE confocal microscope) at 100 magnification. C,
representative extended focus images of three separate experiments. Scale bars, 0.5 m (left panel, single cell images) and 2 m (right panel, multiple cell
images).D, analysis of immunofluorescence data to determine colocalization between Rasa3 and Rap1, Rasa3 and integrinIIb3, and integrinIIb3 and Rap1
(left panel), and submembrane localization (right panel) was performed using Volocity software, with submembrane defined as 0.5 m from the outermost
point of the cell. The results are expressed as means standard deviation (n 3; *, p 0.05).
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Rasa3 Suppresses Basal and PAR1-mediated Rap1 and Ras
Activation in Integrin IIb3-Expressing CHO Cells—To evalu-
ate the role of Rasa3 in regulating the activity of Rap1 and Ras,
we used an established CHO cell line that stably expresses
human integrin IIb3 and tetracycline-inducible thrombin
receptor (protease-activated receptor 1 (PAR1)) and talin (27).
Endogenous Rasa3 expression was undetectable in these cells
(Fig. 1D), and GFP-conjugated wild-type Rasa3 predominantly
localized to the plasmamembrane, as observed for endogenous
Rasa3 in platelets (see Fig. 5A). Expression of wild-type Rasa3
blocked basal levels of Rap1 activation. In contrast, a mutant
form of Rasa3 lacking its N-terminal C2 domains (C2-Rasa3),
a Rap1GAP/RasGAP-inactive Rasa3 (Rasa3 (R371Q)), or a
Rap1GAP-deficient Rasa3 (Rasa3 (P489V)) had no effect (Fig. 4,
B and D, and Table 1) (19, 28). The PAR1 peptide SFLLRN
increased Rap1 activation in CHO cells, which was strongly
reduced by wild-type Rasa3 but unaffected by C2-Rasa3,
Rasa3 (R371Q), and Rasa3 (P489V) (Fig. 4,C and E), confirming
that wild-type Rasa3 expression causes a reduction in active
Rap1-GTP levels specifically through its Rap1GAP activity.
Similarly, PAR1 stimulation of CHO cells caused an increase in
Ras-GTP, and wild-type Rasa3 overexpression caused a reduc-
tion in active Ras levels (Fig. 4, C and E), although not to the
same extent as its effect on active Rap1 (Fig. 4,B andD). Expres-
sion of C2-Rasa3 and Rasa3 (R371Q) had no effect on Ras-
GTP levels, whereas theRap1GAP-deficient P489Vmutant had
similar effects on reducing Ras activation as wild-type Rasa3
(Fig. 4, C and E).
Integrin IIb3-dependent Spreading Is Inhibited by the
Rap1GAP Activity of Rasa3—To explore the role of Rasa3 in
outside-in signaling downstream of integrin IIb3, we per-
formed fibrinogen-spreading experiments of CHO cells trans-
fected with GFP-tagged Rasa3. In platelets, spreading on fibrin-
ogen is a consequence of integrin IIb3-mediated outside-in
signaling (29–31). We first confirmed that spreading of these
CHO cells on fibrinogen is mediated by integrin IIb3 by
blocking spreading using integrin IIb3 antagonist abciximab
(Fig. 5,A andB). Strikingly, expression ofGFP-conjugatedwild-
type Rasa3 blocked spreading of CHO cells on fibrinogen com-
paredwith CHOcells expressingGFP alone (Fig. 5,C andD). In
contrast, GFP-tagged forms of C2-Rasa3, Rasa3 (R371Q), or
Rasa3 (P489V) had no effect on CHO cell spreading on fibrin-
ogen. These results are not due to changes in receptor expres-
sion levels following Rasa3 overexpression because integrin
IIb3 subunit and PAR1 levels were unchanged (data not
shown). Together, these data indicate that Rasa3-dependent
suppression of integrin IIb3-mediated outside-in signaling is
through inhibition of Rap1 and not Ras.
Rasa3 hlb and scat Mutations Cause a Reduction in GAP
Activity and Function—Two Rasa3 mutants present in throm-
bocytopenic mice, Rasa3 (G125V) and Rasa3 (H794L), have
recently been described (8, 32). The Rasa3 (G125V) mutant
protein is proposed to be cytosolic and thus to have deficient
GAP activity (32). TheH794Lmutation causes amarked reduc-
tion in expression of Rasa3 in mice homozygous for this muta-
tion (8). We sought to characterize the effect that these muta-
tions had on Rasa3 GAP activity and integrin IIb3-mediated
spreading. When expressed in resting CHO cells, Rasa3
(G125V) and Rasa3 (H794L) inhibited Rap1-GTP levels in a
similar manner to wild-type Rasa3 (Fig. 6, A and B). Under
SFLLRN-stimulated conditions, however, Rasa3 (G125V) and
Rasa3 (H794L) expression had no effect on Rap1 activation.
Expression of Rasa3 (G125V) and Rasa3 (H794L) had no signif-
icant effect on Ras activation in resting or stimulated cells (Fig.
6, C and D). Because the lack of effect of the Rasa3 H794L
mutant may potentially be caused by lower total expression
levels (Fig. 6, A and D), we also performed in vitro assays using
recombinant forms of Rasa3 (G125V) and Rasa3 (H794L), as
well as wild-type Rasa3 and GAP-inactive mutant R371Q as a
control. As clearly shown, Rasa3 (G125V) and Rasa3 (H794L)
are unable to enhance the GTPase function of major platelet
Rap1 isoform Rap1b or H-Ras (Fig. 6, E and F). To test whether
the changes in GAP activity caused by the G125V and H794L
mutations had an effect on the role of Rasa3 in outside-in sig-
naling, we measured spreading of CHO cells transfected with
these mutants. As expected and similar to other Rasa3 mutants
with perturbed Rap1GAP activity (Fig. 5, C and D), the G125V
and H794L mutations reduced the ability of Rasa3 to inhibit
CHO cell spreading on fibrinogen (Fig. 6, G and H).
Spreading of Rasa3-deficient Platelets Is Insensitive to PI3K
Inhibition—To further explore the effect of the Rasa3 (H794L)
mutation on outside-in signaling, we studied the spreading
of murine platelets expressing Rasa3 (H794L). However,
Rasa3H794L/H794L mice are severely thrombocytopenic, a phe-
notype that is rescued by the concomitant deletion of the Rap1
guanine nucleotide exchange factor (GEF), CalDAG-GEFI (8).
To circumvent the very low platelet count but not abolish
CalDAG-GEFI function, we used platelets from CalDAG-
GEFI/ Rasa3H794L/H794L mice for our spreading experiments
(8). After 60 min of exposure to a fibrinogen-coated surface,
platelets from CalDAG-GEFI/Rasa3H794L/H794L mice were
extensively spread, as opposed towild-type or CalDAG-GEFI/
Rasa3/H794L control platelets that underwent limited spread-
ing (Fig. 7, A and B). Interestingly, spreading of CalDAG-
GEFI/ Rasa3H794L/H794L mouse platelets was unaffected by
treatment with wortmannin, unlike platelets from wild-type
mice, demonstrating that PI3K mediates IIb3-mediated
spreading through regulation of Rasa3.
Discussion
We here characterized the Ras/Rap1GAP Rasa3 as a major
PI(3,4,5)P3 binder and PI3K-regulated protein in human plate-
lets. We have shown for the first time that Rasa3 acts down-
stream of integrin IIb3 to control cell spreading by inactivat-
ing Rap1 and that Rasa3 G125V andH794Lmutations found in
thrombocytopenic mice have a profound effect on Rasa3 func-
tion. Our results support the concept that Rasa3 is closely asso-
ciated with integrin IIb3 and keeps Rap1 in an inactive form.
Integrin-mediated PI3K activity generates PI(3,4,5)P3, which
leads to an inhibition of Rasa3GAP activity, allowing Rap1 acti-
vation and cell spreading to occur.
The Rap1/RasGAP protein Rasa3 was originally purified and
identified from pig platelets in a search for inositol 1,3,4,5-tet-
rakisphosphate-binding proteins and named GAP1IP4BP (18,
33). Rasa3 is a member of the GAP1 family of proteins that
contains a C-terminal pleckstrin homology domain that binds
Role of PI3K/Rasa3 in Integrin Signaling
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to PI(4,5)P2, as well as PI(3,4,5)P3, thus targeting Rasa3 to the
plasma membrane (25, 34). Research into establishing the role
of Rasa3 in platelet function has been hindered by embryonic
lethality of the global Rasa3 knock-out mice and severe throm-
bocytopenia of animal models with impaired Rasa3 expression
(8, 20, 35). A spontaneous G125Vmutation of Rasa3 was found
in scat (severe combined anemia and thrombocytopenia) mice,
which undergo hematological “crises,” whereby blood cells are
FIGURE 4.Rasa3 suppresses Rap1 andRas activation in integrinIIb3-expressing CHO cells. A, CHO cells that were allowed to adhere to glass-bottomed
dishes coated with 0.1 mg/ml poly-L-lysine were transfected with GFP alone (GFP) or GFP-conjugated wild-type Rasa3 (WT Rasa3). 16 h after transfection, cell
medium was replaced with imaging medium, and the cells were imaged on a spinning disk confocal microscope at 63 magnification. The images are
representative of three independent experiments. Scale bar, 20m. B–E, CHO cells were transfectedwith GFP alone or GFP-conjugatedWT Rasa3, Rasa3-C2,
Rasa3 (R371Q), or Rasa3 (P489V). CHO cells were unstimulated or stimulated with 50 M SFLLRN for 5 min. Rap1-GTP or Ras-GTP was extracted from platelets
lysates by GST-RalGDS-RBD or GST-Raf1RBD pulldown, respectively. Pulldown samples were blotted for Rap1 or Ras, and total lysate controls were immuno-
blotted for Rap1 or Ras, pAktS473, GFP, talin, and -tubulin (loading control). B and C, representative blots from at least four independent experiments. D and
E, quantification of Rap1-GTP (D, n 4–9) or Ras-GTP (E, n 4–7) bands by densitometry, expressed asmeans standard deviation of the percentage of the
stimulated GFP control detected. The values are compared with the basal or stimulated GFP control to test for significance (***, p 0.001).
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depleted and take on a diseasedmorphology, also causing even-
tual lethality (32). Furthermore megakaryocytic conditional
Rasa3 knock-out mice were also severely thrombocytopenic,
and mice with a H794L mutation in Rasa3 showed a drastic
reduction in Rasa3 expression and thrombocytopenia (8, 20).
In this study, using an affinity proteomics approach, we iden-
tified Rasa3 as one of the major PI(3,4,5)P3-binding proteins in
human platelets. Furthermore, we found that the majority
(75%) of Rasa3 is localized at the platelet membrane, which
indeed is likely to be mediated through its known interaction
with PI(4,5)P2 (25, 34). Platelet activation resulted in a net
translocation of Rasa3 to the membrane, which was prevented
by the pan-PI3K inhibitor wortmannin, the PI3K p110 inhib-
itor TGX-221, and the P2Y12 blocker AR-C66096, demonstrat-
ing that PI3K-mediated PI(3,4,5)P3 generation results in
increasedmembrane association of Rasa3. This is in agreement
with a previous study showing that in HEK cells, PI(3,4,5)P3
generation causes the loss of the cytosolic portion of Rasa3 and
an increase in Rasa3 plasma membrane association (26). Inter-
estingly, we found a close association between integrin IIb3
and Rasa3 in human platelets, making Rasa3 perfectly posi-
tioned to regulate integrin function.
The most likely mechanism by which Rasa3 regulates integ-
rin and platelet function is through its GAP activity toward
Rap1 and/or Ras. Of these, Rap1 has a well established function
in both inside-out and outside-in regulation of integrins (15, 16,
36), whereas the role of Ras in platelets is currently unknown,
but its potential function is an interesting consideration. Previ-
ous studies have implicated a negative role of H-Ras in integrin
IIb3 activation (37) and, along with this study, have shown
that Ras activation occurs in response to thrombin, PKC stim-
ulation, convulxin, U46619, andTPO in platelets (38, 39). How-
ever, unlike the regulation of Rasa3, Rap1, and integrinIIb3 in
human platelets, we found that Ras activation was not depen-
dent on PI3K, strongly suggesting that PI3K-mediated regula-
tion of Rasa3 is likely to affect Rap1 and not Ras in human
platelets. Our results in recombinant CHO cells that constitu-
tively express integrin IIb3 further support a major role of
Rasa3 in regulating Rap1 activity downstream of integrin
IIb3. Cell spreading on fibrinogen was used as a well estab-
lished assay for studying integrin IIb3-mediated outside-in
signaling independent of inside-out signals and integrin affinity
modulation (31, 40). Expression of Rasa3 reduced both Ras and
Rap1 activation and blocked integrin-mediated CHO cell
spreading on fibrinogen. We confirmed that this effect was
mediated through an effect of Rasa3 on Rap1, and not Ras,
because Rap1GAP-inactive Rasa3 (P489V) was unable to
inhibit CHO cell spreading despite being fully RasGAP-active.
Interestingly, we show here that the H794Lmutation also leads
to impaired Rasa3GAP activity and loses its ability to block integ-
rin-mediated cell spreading in CHO cells. Furthermore, Rasa3
(G125V), a mutation located between the two C2 domains and
present in scatmice, was alsoGAP-inactive. The finding that both
Rasa3 (H794L) and (G125V) were both intrinsically Rap1GAP-
and RasGAP-inactive was interesting given our previous work
showing that Rasa3 C2 domain or C-terminal tail deletion
mutants, containing the respective locations of G125 and H794
(Fig. 1A), were only Rap1GAP-inactive, retaining full RasGAP
activity (28). It therefore seems likely that the H794L and G125V
mutations affect Rasa3 protein structure or Ras-binding, signifi-
cantly diminishing RasGAP activity.
Together, our data demonstrate the important role of Rasa3/
Rap1 in integrin-mediated outside-in signaling and cell spread-
ing. Rasa3 is also likely to contribute to inside-out signaling,
because platelets from Rasa3H794L/H794L mice had increased
Rap1 activity and integrin IIb3 activation (8). Crossing
Rasa3H794L/H794L mice with mice deficient in the RapGEF
CalDAG-GEFI reversed increased platelet integrin activation
and partially normalized platelet count and life span (8), dem-
onstrating that Rasa3 regulation of Rap1 underlies the pheno-
type. To confirm the role of Rasa3 in outside-in signaling in
platelets, we utilized the Rasa3H794L/H794L mouse model, with
a slight variation in that they were also heterozygous for
CalDAG-GEFI to ensure sufficient platelet numbers (8).
CalDAG-GEFI/Rasa3H794L/H794L platelets exhibited in-
creased spreading on fibrinogen, demonstrating that Rasa3 pre-
vents spreading downstream of integrin engagement.
This result corroborates with previous work showing the
involvement of Rap1 in integrin-mediated spreading and the find-
ing that platelets from patients with a mutation in CalDAG-GEFI
have deficient spreading (17, 36, 41, 42). It is well established that
integrin IIb3 outside-in signaling and subsequent cell spreading
is dependent on PI3K (this study and Ref. 4), and we hypothesize
that one of the major mechanisms by which PI3K regulates out-
side-in signaling is by inhibiting Rasa3 Rap1GAP activity (Fig. 8).
Indeed, the importance of PI3K in the regulation of Rasa3 down-
stream of integrinIIb3 was clearly demonstrated by the insensi-
tivity of integrin IIb3-mediated spreading of CalDAG-GEFI/
Rasa3H794L/H794L platelets to a PI3K inhibitor.
Taken together, our results provide new insight into the
mechanism by which PI3K regulates platelet function, in par-
ticular by controlling Rasa3 downstream of integrin IIb3. We
propose that PI3K regulates Rap1 activation downstream of
integrinIIb3 by inhibition of Rasa3Rap1GAPactivity, leading
to sustained Rap1 activation and cell spreading.
TABLE 1
Summary of Rasa3 mutants
The table includes the location of eachmutant and a description of the effect themutation has onRasa3 localization and activity. The effects onRasa3 not shown in this study
are referenced as appropriate. RasGAP, RasGAP-related domain.
Rasa3 Mouse model Location Effect on Rasa3
C2 Deletion of C2 domains Required to stabilize RasGAP domain (28)
Loss of GAP activity
R371Q RasGAP Loss of GAP activity
P489V RasGAP RapGAP-deficient
G125V scat Between C2 domains Mislocalization to cytosol (32); loss of GAP activity
H794L hlb381 C terminus Reduced expression in Rasa3hlb/hlb mice (8); loss of GAP activity
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Experimental Procedures
Materials—Goat anti-Rasa3 (sc-34468), rabbit anti-Rap1 (sc-
65), goat anti-Btk (Bruton’s tyrosine kinase) (sc-1107), mouse
anti-integrin IIb3 (sc-21783), and goat anti-talin (sc-7534)
antibodies were obtained from Santa Cruz Biotechnology
(Insight Biotechnology, Wembley, UK). Rabbit anti-FcR (06–
727) andmouse anti-Ras (05–516) (recognizing p21H-, K-, and
N-Ras) antibodies were from Millipore (Billerica, MA). Rabbit
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anti-pS473 Akt (4060), rabbit anti-Akt (9272), rabbit anti-ERK
(9102), and rabbit anti-GFP (2555) antibodies were sourced
from Cell Signaling Technologies (New England Biolabs,
Hitchin, UK), and the rat anti-GPIX (M051-0) antibody was
from Emfret Analytics (Wuerzburg, Germany). PE-conjugated
mouse anti-CD61 (555754) antibody was from BD Biosciences
(Oxford, UK), and PE-conjugated mouse anti-PAR1 (IM2584)
antibody and DRAQ7 were from Beckman Coulter (High
Wycombe, UK). Secondary peroxidase-conjugated antibodies
were from Jackson Immunoresearch (Stratech, Newmarket,
UK). Control and PI(3,4,5)P3-coated beads were from Tebu-
bio (Peterborough, UK). Alexa Fluor 350/488/568-conju-
gated secondary antibodies, PE-conjugated mouse anti-
CD41 (MHCD4104) and mouse IgG1 (MG104) antibodies
Lipofectamine 2000 and NuPAGE LDS sample buffer were
obtained from Life Technologies (Carlsbad, CA). Enhanced
chemiluminescent materials, GSH-Sepharose beads, and PD-
10 desalting columnswere sourced fromGEHealthcare. PAR1-
activating peptide (SFLLRN) was from Bachem (Weil am
Rhein, Germany), and abciximab was from Eli Lily (Basing-
stoke, UK). cOmpleteMini protease inhibitor tablets were from
Roche Applied Science, and microcystin-LR was from Axxora
(Nottingham, UK). BL21(DE3)pLysS competent cells were
obtained from Promega (Southampton, UK). AR-C 66096 and
wortmannin were from Tocris (Avonmouth, UK). TGX-221
was from Selleckchem (Houston, TX). [-32P]GTP was from
PerkinElmer Life Sciences. Fibrinogen used in the mouse
spreading experiments was sourced from Enzyme Research
Laboratories (South Bend, IN). All other reagents were
obtained from Sigma-Aldrich unless stated otherwise.
Construction of Rasa3 Mutants—Rasa3-pEGFP-C1 and
C2Rasa3-pEGFP-C1 have been described previously (25).
Site-directed mutagenesis of Rasa3 in pEGFP-C1 was carried
out as described by the manufacturer (QuikChange II; Agilent
Technologies) using the following primers: 5	-cccaggatcccaac-
accatcttccaaggaaactc-3	 (R371Q), 5	-ggttctttgcggtcgcgattctc-
tccccc-3	 (P489V), 5	-gactcggaagtgcaggtcaaagtgcacctggag-3	
(G125V), and 5	-GGGGCTTTGGAGCAGGAGCTCGCCCA-
GTATAAGAGGGACAA-3	 (H794L). All mutated codons are
underlined and were confirmed by DNA sequencing.
Preparation of GST-tagged RafGDS-RBD and RalGDS-
RBD—Plasmids encoding GST-RafGDS-RBD and GST-RalGDS-
RBD were heat shock transfected into BL21(DE3)pLysS com-
petent cells and grown on agar plates containing LB-Amp
(Luria-Bertani 50g/ml ampicillin). Single colonies of trans-
formed bacteria were grown for 24 h at 37 °C before being
diluted in 1 liter of LB-Amp. Proteinwas inducedwith the addi-
tion of 1 mM isopropyl -D-thiogalactopyranoside for 3 h, and
bacteria were pelleted (6000  g, 20 min, 4 °C) and stored at
80 °C overnight. Bacteria resuspended in RBD buffer (PBS, 5
mMMgCl2, 1%Triton X-100, 1mMPMSF, 5mMDTT, protease
inhibitors) were sonicated and tumbled with GSH-Sepharose
beads for 30min. The beadswere pelleted (500 g, 5min, 4 °C),
washed with storage buffer (RBD buffer 5% glycerol), resus-
pended in elution buffer (RBD buffer  15 mM reduced L-glu-
tathione), and loaded onto PD-10 desalting columns. Eluates
containing the GST-tagged proteins were collected by washing
the columns with storage buffer.
Isolation of PrimaryCells andCell Culture—Humanplatelets
(13), mouse platelets (8, 43) andmegakaryocytes (44) were pre-
pared as described previously. Peripheral blood mononuclear
cells were isolated with Histopaque (Sigma-Aldrich) according
to the manufacturer’s instructions. CHO-K1 cells expressing
IIb3 and inducible PAR1/talin (gift from S. Shattil) were cul-
tured as described (27). The cells were transfected with Lipo-
fectamine (Life Technologies) following the manufacturer’s
protocol, followed by doxycycline treatment to induce PAR1/
talin expression for 24 h.
Capture of PI(3,4,5)P3-binding Proteins fromHuman Platelet
Lysates—Resting platelets were pelleted at 520  g for 10 min
and lysed in ice-cold lysis buffer (20mMHEPES, pH 7.4, at 4 °C,
120 mMNaCl, 0.5% Nonidet P-40, 5 mM EGTA, 5 mM EDTA, 5
mM -glycerophosphate, 10 mM NaF, 1 mM Na3VO4, and pro-
tease inhibitors). Following vortexing and tumbling for 20 min
at 4 °C, the lysates were centrifuged at 16,000 g for 10 min at
4 °C. The resulting supernatants were incubated in the pres-
ence or absence of 40 M PI(3,4,5)P3 for 20 min at 4 °C under
gentle rotation, before addition to 30 l of pre-equilibrated
control or PI(3,4,5)P3 beads for 90 min at 4 °C under gentle
rotation. The beads were washed three times with ice-cold lysis
buffer. The proteins were processed forWestern blotting or for
mass spectrometry.
Mass Spectrometry—Proteomics was performed as previ-
ously described (45), with a fewmodifications. A single gel slice
for each pulldown was subjected to in-gel tryptic digestion
using a ProGest automated digestion unit (Digilab UK). The
resulting peptides were fractionated using a Dionex Ultimate
3000 nanoHPLC system in line with an LTQ-Orbitrap Velos
mass spectrometer controlled by Xcalibur 2.1 software
(Thermo Scientific) operated in data-dependent acquisition
mode. The raw data files were processed and quantified using
Proteome Discoverer software v1.2 (Thermo Scientific) and
searched against the UniProt Human database (122604
sequences) using the SEQUEST (Ver. 28 Rev. 13) algorithm.
The reverse database search optionwas enabled, and all peptide
data were filtered to satisfy a false discovery rate of 5%.
FIGURE5. IntegrinIIb3-mediatedspreadingofCHOcells is inhibitedbyRasa3Rap1GAPactivity.AandB, CHOcellswereallowed toadhere to100g/ml
fibrinogen, in the absence or presence of 10 g/ml abciximab, at 37 °C. Adherent cells were fixed and stained with CruzFluor 594-phalloidin (red) and DAPI
(blue). Images were acquired using a Leica AF6000 wide field microscope at 40magnification. A, representative images of spread CHO cells in the absence
(abcix) or presence (abcix) of 10 g/ml abciximab. Scale bar, 32 m. B, cell area was analyzed by measuring the phalloidin staining per cell using ImageJ
software. The results are expressed as means  standard deviation (n  4; ***, p  0.001). C and D, CHO cells were transfected with GFP alone or GFP-
conjugatedWTRasa3, Rasa3-C2, Rasa3 (R371Q), or Rasa3 (P489V) and then allowed to adhere to 100g/ml fibrinogen at 37 °C. Adherent cells were fixed and
stained with CruzFluor 594-phalloidin (red) and DAPI (blue). Prior to the spreading assay, CHO cells were transfected with GFP alone or GFP-conjugated WT
Rasa3, Rasa3-C2, Rasa3 (R371Q), or Rasa3 (P489V). GFP (green) expression indicates transfected cells. The images were acquired using a Leica AF6000 wide
field microscope at 40 magnification. C, representative images of spread CHO cells transfected with GFP, WT Rasa3, Rasa3-C2, Rasa3 (R371Q), or Rasa3
(P489V). Scale bar, 32m.D, cell area was analyzed bymeasuring the phalloidin staining per cell using ImageJ software. The results are expressed asmeans
standard deviation compared with GFP control (n 3–7; ***, p 0.001).
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Protein Extraction and Immunoblotting—Washed plate-
lets were incubated with 100 nM wortmannin, 1 M AR-C
66096 or vehicle for 10 min and stimulated with 0.2 unit/ml
thrombin for the indicated time. Alternatively, CHO cells
were stimulated with 50 M SFLLRN for 5 min. The samples
were lysed in ice-cold 2 radioimmune precipitation assay
buffer (50 mMHEPES, pH 7.4, 400 mMNaCl, 2 mM EDTA, 2%
(v/v) Nonidet P-40, 1% (w/v) sodium deoxycholate, 0.2%
(w/v) SDS, 40 mM sodium -glycerophosphate, 20 mM
sodium pyrophosphate, 2 mM benzamidine, protease inhib-
itors, 10 mM Na3VO4, and 2 M microcystin-LR) for whole
cell lysates or ice-cold 2 Rap1 lysis buffer (50 mM HEPES,
pH 7.4, 400 mM NaCl, 5 mM MgCl2, 2% (v/v) Nonidet P-40,
20% glycerol, protease inhibitors, 10 mM Na3VO4, and 2 M
microcystin-LR) for pulldown samples. Lysates were incu-
bated on ice for 30 min, and proteins were extracted in the
supernatant of centrifuged lysates (4 °C, 16,200 g, 10 min).
A Bradford assay was performed to determine the approxi-
mate protein concentration of whole cell lysates. For West-
ern blotting, lysates were mixed with 4 sample buffer
(NuPAGE LDS sample buffer  50 mM DTT) and processed
for SDS-PAGE and immunoblotting as previously described
(46).
Rap1 and Ras Activation Assays—Purified GST-RafGDS-
RBDandGST-RalGDS-RBDproteinswere bound toGSH-Sep-
harose beads overnight at 4 °C. Pulldown samples in Rap1
buffer were incubated on ice for 20min to complete extraction,
and proteins were extracted in the supernatant of centrifuged
lysates (16,200 g, 10 min, 4 °C). Platelet lysates were tumbled
with 20 g of immobilized GST-RafGDS-RBD or GST-Ral-
GDS-RBD for 1 h at 4 °C to pull down Ras-GTP or Rap1-GTP,
respectively. The beads were repeatedly pelleted (4 °C,
FIGURE 6. Rasa3 hlb and scat forms have deficient RasGAP activity and reduced Rap1GAP activity upon stimulation. A–D, CHO cells were transfected
with GFP alone or GFP-conjugatedWT Rasa3, Rasa3 (H794L), or Rasa3 (G125V), and Rap1-GTP (A) or Ras-GTP (D) activation assayswere carried out as described
for Fig. 4 (B–E). A and D, representative blots from at least four independent experiments. B and C, quantification of blots, expressed as means  standard
deviation of the percentage of the stimulatedGFP control (B, n 4–6;C, n 4–6) detected. The values are comparedwith the basal or stimulatedGFP control
to test for significance (*, p  0.05; **, p  0.01; ***, p  0.001). E and F, 25 nM recombinant Rasa3 (WT, R371Q, H794L, or G125V) was incubated with
[-32P]GTP-loaded1MRap1borH-Ras for 10minat 25 °C, andGAPactivitywasmeasuredasdescribedunder “Experimental Procedures” (n3; ***,p0.001).
G and H, CHO cells were transfected with GFP alone or GFP-conjugated WT Rasa3, Rasa3 (H794L), or Rasa3 (G125V) and then allowed to adhere to 100 g/ml
fibrinogenat 37 °C. Adherent cellswere fixedand stainedwithCruzFluor 594-phalloidin (red) andDAPI (blue). GFP (green) expression indicates transfected cells.
Images were acquired using a Leica AF6000 wide field microscope at 40 magnification. G, cell area was analyzed as described for Fig. 5D. The results are
expressed asmeans standard deviation comparedwith GFP control (n 4–5; ***, p 0.001).H, representative images of spread CHO cells transfectedwith
GFP, WT Rasa3, Rasa3 (H794L), or Rasa3 (G125V). Scale bar, 32 m.
FIGURE 7.SpreadingofRasa3H794L/H794Lmouseplatelets on fibrinogen.Platelets fromCalDAG-GEF1/Rasa3H794L/H794Lmicewere incubatedwith 100nM
wortmannin or vehicle control for 10minbefore being allowed to spreadon100g/ml fibrinogen for 60min at 37 °C. After fixation, plateletswere stainedwith
Alexa Fluor 594-phalloidin.A, representative images of spread platelets fromwild-type, CalDAG-GEF1/ Rasa3/H794L, and CalDAG-GEF1/ Rasa3H794L/H794L
mice. Scale bar, 10 m. B, quantification of platelet spreading by measuring the extent of phalloidin staining per platelet using ImageJ software (n 3).
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16,200 g, 20 s) and washed with Rap1 buffer before elution in
NuPAGE LDS sample buffer.
Platelet Fractionation—Stimulated platelets were diluted in
an equal volume of sonication buffer (50 mM Tris, pH 7.4, 250
mM sucrose, protease inhibitors, 10 mM Na3VO4, and 2 M
microcystin-LR) and sonicated (five times for 20 s). The lysate
was centrifuged (1500 g, 10min, 4 °C) to remove intact plate-
lets, and the membrane fraction was pelleted (100,000 g, 2 h,
4 °C). The supernatant (cytosolic fraction) was removed, and
the pellet was resuspended in radioimmune precipitation assay
buffer.
Immunofluorescence—Stimulated and untreated platelets
were fixed in 4% formaldehyde and spun onto glass coverslips
(180 g, 5 min). Adhered platelets were washed with PBS and
permeabilized with 0.1% Triton X-100. 1% fatty-acid free BSA
was added for 1 h at room temperature before overnight incu-
bation with primary antibodies (1:500) at 4 °C. Excess antibody
was washed off, and the samples were incubated with Alexa
Fluor 350/488/468-conjugated anti-rabbit/goat/mouse anti-
bodies for 1 h at room temperature. Coverslips were mounted
onto slides and imaged with a 100 oil objective lens (numer-
ical aperture, 1.4) using a spinning disk confocal module
(PerkinElmer UltraVIEW ERS 6FE confocal microscope)
equipped with a C9100–50 EM-CCD camera (Hamamatsu).
Analysis was performed using Volocity software (PerkinElmer)
on at least 20 cells, with submembrane defined as 0.5 m from
the outermost point of the cell.
CHOCell Spreading Assay—Coverslips were coatedwith 100
g/ml fibrinogen overnight at 4 °C followed by the addition of
2% (w/v) fatty-acid free BSA for 2 h at 37 °C. 1 106 transfected
CHO cells were allowed to adhere to fibrinogen for 30 min at
37 °C. Some cells were incubated with 10 g/ml abciximab
prior to adhesion. Non-adherent cells were washed away, and
cells were fixed in 4% formaldehyde for 10 min, permeabilized
with 0.1% Triton X-100, and stained with CruzFluor 594-phal-
loidin and DAPI. Images were acquired using a Leica AF6000
wide field microscope equipped with a dry 40 objective lens
(numerical aperture, 0.6) and a DFC365FX monochrome CCD
camera (Leica). Cell area was analyzed by measuring the phal-
loidin staining per cell using ImageJ software.
Mouse Platelet Spreading Assay—Glass-bottomed plates
were coated with 100 g/ml fibrinogen for 1 h followed by the
addition of 3% (w/v) BSA for 30min.Washedmouse platelets at
7.5 107/ml were allowed to adhere to fibrinogen for the indi-
cated time at 37 °C in the presence of 2 mM Ca2. Some cells
were incubated with 100 nM wortmannin or vehicle control
prior to adhesion. The cells were fixed in an equal volume of 4%
formaldehyde for 10 min, permeabilized with 0.1% Triton
X-100, and stained with Alexa Fluor 647-GPIX antibody and
Alexa Fluor 594-phalloidin to visualize platelets and F-actin,
respectively. Image acquisition and cell area quantification
were performed as above.
GAP Activity Assays—Assays to determine Rasa3 (H794L)
and (G125V) GAP activity were performed as previously
FIGURE 8. Role of Rasa3 and PI3K in platelet integrin IIb3 outside-in signaling. A, fibrinogen binding to activated integrin IIb3 initiates outside-in
signaling, including the activation of PI3K. PI3K reduces Rasa3 Rap1GAP activity, thus allowing CalDAG-GEFI-mediated Rap1 activation to occur uninhibited.
ActivatedGTP-bound Rap1 then promotes further signaling processes that lead to cell spreading. B, Rap1GAP-inactive forms of Rasa3 (shown in “red”), such as
Rasa3 (H794L), are unable tomediate Rap1 inactivation, leading to enhanced cell spreading. C, inhibition of PI3K bywortmannin releases the Rap1GAP activity
of Rasa3, thus enabling the conversion of Rap1 into its inactive GDP-bound state. As a result, cell spreading is severely reduced. Note that the role of PI3K in
platelet spreading is upstream of Rasa3, and therefore cells containing intrinsically Rap1GAP-inactive forms of Rasa3 are insensitive to PI3K inhibition.
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described under first order kinetics and using 25 M recombi-
nant Rasa3 per assay (18). Each experiment was performed in
triplicate.
Imaging Rasa3 Localization in CHO Cells—CHO cells were
seeded onto poly-L-lysine-coated glass-bottomed dishes (1 
105 cells/dish) overnight under normal growing conditions,
before the cells were transfected with GFP or GFP-conjugated
wild-type Rasa3. 16 h after transfection, the adhered cells were
washed twice in imaging medium (phenol red-free DMEM, 25
mMHEPES, 10% FCS) and incubated at 37 °Cwithout CO2. The
cells were imaged with a 63 glycerol objective lens (numerical
aperture, 1.3) using the previously described spinning disk con-
focal module and camera.
Flow Cytometry—CHO cells were harvested and resus-
pended in FACS Tyrode’s (12.1 mM NaHCO3, 10 mM HEPES,
137 mM NaCl, 2.6 mM KCl, 5.6 mM glucose, 1 mg/ml BSA)
containing 1 mM CaCl2 and 1 mM MgCl2. CHO cells were then
incubatedwith 200 ng of PE-conjugatedCD41, CD61, PAR1, or
isotype control for 30 min on ice. Samples were analyzed on a
FACSCanto II flow cytometer and gated for living (DRAQ7)
and transfected (GFP) cells.
Statistics—The data were analyzed using GraphPad Prism
software. All error bars show the means standard deviation.
Statistical analysis is presented as paired Student’s t test or anal-
ysis of variance (one-way or two-way) followed by Dunnett’s
post test (*, p 0.05; **, p 0.01; ***, p 0.001).
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